ORBITAL THERAPEUTICS Trademark
ORBITAL THERAPEUTICS is a USPTO trademark filed by Orbital Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | ORBITAL THERAPEUTICS |
|---|---|
| Serial Number | 98597164 |
| Status | Pending |
| Filing Date | 2024-06-12 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Orbital Therapeutics, Inc. |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 29 |
| Latest Event | EXRA on 2026-04-28 |
Goods & Services
Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Pharmaceutical preparations in the nature of protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Therapeutic and preventative vaccines; Medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; RNA-based therapeutics for the treatment and prevention of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; Therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; "THERAPEUTICS"; Research and development in the biotechnology field; Consulting services in the fields of biotechnology and genetic science; Development of new technology for others in the fields of genomics and biotechnology; Providing laboratory research services in the field of gene expression or RNA-based therapeutics; Testing, inspection, research, or development of chemical and biotechnology preparations; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids